Evidence map›Paper›PMID 39895631›Full record

ArticleThe Journal of clinical investigation2025

HMGA1 is a crucial mediator of colon tumorigenesis driven by the loss of APC.

Yuxiang Wang, Mikayla Ybarra, Zhenghe Wang

Abstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuxiang WangDepartment of Genetics and Genome Sciences and.
Mikayla YbarraDepartment of Genetics and Genome Sciences and.
Zhenghe WangDepartment of Genetics and Genome Sciences and.

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Amar Desai · 1987 to 2026
$142.3M
Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutationsR01CA196643 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Zhenghe Wang · 2016 to 2026
$3.1M
Role of Erbb3 kinase activity in colorectal tumorigenesis.R01CA256791 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, ZHENGHE · 2021 to 2025
$2.5M
Role of PTPRT in colon cancer progression and metastasisR01CA260629 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, ZHENGHE · 2022 to 2025
$2.2M
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesisR01CA264320 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, ZHENGHE · 2021 to 2025
$2.0M
NCI NIH HHS P30 CA043703NCI NIH HHS P50 CA150964NCI NIH HHS R01 CA196643NCI NIH HHS R01 CA256791NCI NIH HHS R01 CA260629NCI NIH HHS R01 CA264320
6 · The paper itself

Abstract

Colorectal cancer is the second leading cause of cancer death in the United States. The adenomatous polyposis coli (APC) pathway plays a critical role in colorectal tumorigenesis, but the mechanism is not fully understood. In this issue of the JCI, Luo and colleagues used genetically engineered mouse models to show that high mobility group A (HMGA1) is a critical mediator in the development of colon tumors driven by the loss of the Apc gene. HMGA1 activated the transcription of Achaete-Scute Family BHLH Transcription Factor 2 (ASCL2), which regulated intestinal stemness and promoted colon tumorigenesis.

Indexed as

Adenomatous Polyposis Coli ProteinCarcinogenesisColonic NeoplasmsGenes, APCHMGA1a ProteinAnimalsBasic Helix-Loop-Helix ProteinsHumansMiceMice, KnockoutAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mouseBasic Helix-Loop-Helix ProteinsHMGA1a Protein

Identifiers

PMID39895631
PMCPMC11785912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.